Nationwide Snack Recall Update As FDA Sets Highest Risk Level
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
Drugmakers to stop making controversial fentanyl lollipops, FDA says
Drugmaker Cephalon had the FDA's approval to market these drugs, old under brand names like Actiq, as a sweetened lozenge on ...
US FDA approves Zevra's treatment for rare genetic disease
The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, making it the ...
Waffle Recall Update As FDA Sets Risk Level for 13 States
The products were voluntarily recalled "due to the potential presence of soft plastic film," leading them to be given a Class ...
STAT1d
FDA’s new head of device safety held senior role at company troubled by safety warnings
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
The American Journal of Managed Care1d
FDA Approves Amivantamab for EGFR-Positive NSCLC With Exon 19 Deletion, Exon 21 L858R Substitution
The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...
Fudge Recall Update As FDA Sets Risk Level Over Mold
The Canadian-based firm Authentik Fudge initiated the recall of the Chocolate Fudge with Nuts products in August.
Medpage Today on MSN2d
FDA Rejects NK1R Antagonist for Gastroparesis
Support for the neurokinin-1 receptor (NK1R) antagonist included a negative phase III trial and a positive phase II study ...